Topline

shape

Homepage Companies Prevail Therapeutics

Prevail Therapeutics

Locations: 430 E 29th St New York, 10016, US

Company Size: 1 - 100

Industry: Biotechnology

Company Website

AI Description

Lynne Verselis

Director, Clinical Development at Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company

View Details

Gold Feature:
Click to upgrade to our gold package for the full feature experience.
Andrew Pla

Sr. Principal Scientist, Analytical Development at Prevail Therapeutics

View Details

Gold Feature:
Click to upgrade to our gold package for the full feature experience.
Stephanie Hussain-Bergman

View Details

Gold Feature:
Click to upgrade to our gold package for the full feature experience.
Ken Cunningham

Principal Engineer at Prevail Therapeutics

View Details

Gold Feature:
Click to upgrade to our gold package for the full feature experience.
Jeremiah Hendricks

Senior Principal Scientist at Prevail Therapeutics

View Details

Gold Feature:
Click to upgrade to our gold package for the full feature experience.
Patricia Sondergaard

Executive Director, Global Regulatory Affairs at Prevail Therapeutics

View Details

Gold Feature:
Click to upgrade to our gold package for the full feature experience.
Carnel St. Louis

Laboratory Operations at Prevail Therapeutics

View Details

Gold Feature:
Click to upgrade to our gold package for the full feature experience.

Showing 1 to 7 of 40 results

‹ Prev 1 2 3 4 5 6 Next ›